Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis
Conclusion:
Providing patients who declined warfarin therapy with information about their genetic risk of AF would be cost effective if this genetic risk information resulted in modest increases in adherence.
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Dov ShiffmanMarco PerezLance BareJudy LouieAndre ArellanoJames Devlin Source Type: research
More News: Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Coumadin | Genetics | Heart | Stroke | Study | Warfarin